Clinical Trial

Clinical Trial of Lactiplantibacillus Plantarum Dad-13 on Gut Microbiota Profile and Performance in Adolescent Athletes

Study acronym: Dad-13
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 23, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this research is to analyze the effect of a Lactiplantibacillus plantarum Dad-13 supplementation on the gut microbiota profile and performance of adolescent athletes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-12.
Trial Details
NCT Number NCT07476573
Lead Sponsor Gadjah Mada University
Conditions Athlete, Probiotic, Performance, Gut Microbiota
Enrollment 30 participants
Start Date 2026-04-13
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-23